Amphastar Pharmaceuticals (AMPH) Net Income towards Common Stockholders (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) recorded Net Income towards Common Stockholders of $30.35 million in Q2 2026, down 2.2% from $31.03 million a year earlier but up 372.7% from the prior quarter.
Amphastar Pharmaceuticals (AMPH) Net Income towards Common Stockholders (2013 - 2026) Analysis & Trends
On a TTM basis, Amphastar Pharmaceuticals' Net Income towards Common Stockholders came in at $78.55 million as of Jun 30, 2026, down 41.7% year-over-year; for FY2025, it came in at $98.09 million, down 38.5% from FY2024.
- Annual Net Income towards Common Stockholders has a five-year compound annual growth rate of 133.8% (FY2020 to FY2025).
- Across earlier years, Net Income towards Common Stockholders came in at $159.52 million in FY2024 (+16.0%), $137.55 million in FY2023 (+50.5%), $91.39 million in FY2022 (+47.1%) and $62.12 million in FY2021.
- Quarterly Net Income towards Common Stockholders has ranged from $6.42 million in Q1 2026 to $49.22 million in Q3 2023 over the past five years.
- On a year-over-year basis, Net Income towards Common Stockholders has declined for six consecutive quarters, with an average decline of 30.3% over the last eight quarters.
- Peak year-over-year performance for Net Income towards Common Stockholders in the last five years was growth of 654.0% in Q3 2021, against a decline of 74.6% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.42 million (Q1 2026), $24.43 million (Q4 2025) and $17.35 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Amphastar Pharmaceuticals | 1.08 Bn | -59.50 Mn | 93.47 Mn | 30.35 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.35 Mn |
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 24.43 Mn |
| Sep 30, 2025 | 17.35 Mn |
| Jun 30, 2025 | 31.03 Mn |
| Mar 31, 2025 | 25.29 Mn |
| Dec 31, 2024 | 37.96 Mn |
| Sep 30, 2024 | 40.43 Mn |
| Jun 30, 2024 | 37.95 Mn |
| Mar 31, 2024 | 43.18 Mn |
| Dec 31, 2023 | 36.17 Mn |
| Sep 30, 2023 | 49.22 Mn |
| Jun 30, 2023 | 26.12 Mn |
| Mar 31, 2023 | 26.03 Mn |
| Dec 31, 2022 | 33.91 Mn |
| Sep 30, 2022 | 15.87 Mn |
| Jun 30, 2022 | 17.35 Mn |
| Mar 31, 2022 | 24.25 Mn |
| Dec 31, 2021 | 19.76 Mn |
| Sep 30, 2021 | 29.55 Mn |
Amphastar Pharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();